Generic FDC drug vs two monoproduct drug or vs "originator" FDC drug? [Design Issues]

posted by Beholder  – Russia, 2018-09-04 09:12 (1021 d 10:48 ago) – Posting: # 19234
Views: 3,247

Hello to everybody!

There is generic FDC drug named AB which is intended to be studied in BE study. There are two options to choose reference drug (s) for that study:
1. two separate monoproducts - named drug A and drug B. Both drugs considered as reference drugs
2. "original" FDC drug named AB which is also considered as reference drug.
Which drug (s) to choose as reference drug (s)? What would be your opinion?
THX in advance.

Best regards

Complete thread:

 Admin contact
21,530 posts in 4,499 threads, 1,524 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Monday 20:00 UTC (Europe/Vienna)

Young man, in mathematics you don’t understand things.
You just get used to them.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz